Managing Patient Samples for Cancer Discoveries
Core 1: Biospecimen and Translational Pathology Core
This core helps cancer researchers by carefully collecting and preparing patient samples, like tissues and blood, from clinical trials to support new discoveries.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11187076 on NIH RePORTER |
What this research studies
This core is essential for cancer research, as it collects and prepares biological samples such as tissues, tumor cells, and blood from patients participating in clinical trials. These samples are carefully processed and stored, and detailed information about each patient's condition is added. This meticulous work ensures that researchers have high-quality materials to study cancer and develop new treatments. By providing these vital resources, the core helps advance our understanding of various cancers, including melanoma and skin cancers.
Who could benefit from this research
Good fit: Patients participating in cancer clinical trials at the Hillman Cancer Center, especially those with melanoma and skin cancers, may have their samples collected and used by this core.
Not a fit: Patients not involved in clinical trials or those whose conditions are not studied by the associated SPORE projects may not directly benefit from this core's activities.
Why it matters
Potential benefit: If successful, this core's work will provide high-quality biological samples and data, accelerating the discovery of new cancer treatments and improving patient care.
How similar studies have performed: This core builds upon a long history of successful specimen collection and immunological monitoring services at the Hillman Cancer Center, supporting numerous cancer immunotherapy studies.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Karunamurthy, Arivarasan — University of Pittsburgh at Pittsburgh
- Study coordinator: Karunamurthy, Arivarasan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.